Healthcare
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Partnership brings Nociscan for chronic low back pain to one of the nation's leading neurosurgery and spine care networksGoodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training and clinical researchAvailability of Nociscan in Indiana reflects Company’s focus on expansion and adding to its growing base of provider sites across the country BROOMFIELD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),
About this update from Aclarion, Inc.
BROOMFIELD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, marking the first site in Indiana to offer the technology. The addition of Goodman Campbell Brain & Spine extends Aclarion's provider network into a new state and aligns the Company with a center that is consistently ranked among the best in the nation. As a leader in neurosurgery training and clinical research, the physician specialists are recognized for their commitment to cutting-edge approaches and treatment, and data-driven outcome measures to improve the health of their patients. "Every patient we see with chronic low back pain deserves a clear answer about where their pain is coming from before we talk about treatment. For years, MRI alone hasn't been able to give us that answer, it shows us the anatomy, but not which disc is actually the source of pain," said Dr. Eric A. Potts, Neurosurgeon and Spine Specialist at Goodman Campbell Brain & Spine and past Chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Section on Disorders of the Spine and Peripheral Nerves. "Bringing Nociscan into our practice reflects the standard we hold ourselves to at Goodman Campbell: if there's a tool that gives our patients and our team better information, we want to be among the first to offer it." Nociscan uses Magnetic Resonance Spectroscopy (MRS) to extract and quantify chemical biomarkers associated with disc pain. The objective, non-invasive insights provided by Nociscan enable physicians to distinguish between painful and nonpainful discs in the lumbar spine -- information that MRI cannot provide. Nociscan provides critical insights into the location of a patient's low back pain and demonstrates a 97% surgical success rate when all Nociscan-positive discs are treated. "Goodman Campbell's reputation for clinical excellence and its role in training the next generation of neurosurgeons make them an important addition to the Nociscan network," said Brent Ness, CEO of Aclarion. "The ...